# Hepcidin After Intravenous Iron Treatment

> **NCT06264687** · — · UNKNOWN · sponsor: **Pierre-Alexandre Krayenbühl** · enrollment: 10 (estimated)

## Conditions studied

- Iron Deficiency (Without Anemia)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06264687
- **Lead sponsor:** Pierre-Alexandre Krayenbühl
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06264687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06264687, "Hepcidin After Intravenous Iron Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06264687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*